Dataset: Defective ribosomal protein gene expression alters transcription, translation, apoptosis, and oncogenic pathways in Diamond-Blackfan anemia.
Transcriptome profile of highly purified multipotential (P), erythroid (E), and myeloid (M) bone marrow progenitors from three RPS19...
Transcriptome profile of highly purified multipotential (P), erythroid (E), and myeloid (M) bone marrow progenitors from three RPS19 mutated Diamond-Blackfan anemia and six control human subjects. Two group comparison of sex and age matched subjects. Bone marrow progenitors, gene expression profiling, Diamond-Blackfan anemia, RPS19
- Species:
- human
- Samples:
- 27
- Source:
- E-GEOD-41599
- PubMed:
- 16741228
- Updated:
- Dec.12, 2014
- Registered:
- Jun.18, 2014
Factors:
(via ArrayExpress)
| Sample | DISEASE STATUS | AGE | SEX | CELL TYPE | SUBJECT ID |
|---|---|---|---|---|---|
| GSM1019956 | DiamondâBlackfan anemia | 42 year old | male | multipotential P, CD34+, CD71â, CD45RAâ | D3 |
| GSM1019955 | DiamondâBlackfan anemia | 42 year old | male | myeloid M, CD34+, CD71 low, CD45RA+ | D3 |
| GSM1019954 | DiamondâBlackfan anemia | 42 year old | male | erythroid E, CD34+, CD71 hi, CD45RAâ | D3 |
| GSM1019953 | DiamondâBlackfan anemia | 30 year old | male | multipotential P, CD34+, CD71â, CD45RAâ | D2 |
| GSM1019952 | DiamondâBlackfan anemia | 30 year old | male | myeloid M, CD34+, CD71 low, CD45RA+ | D2 |
| GSM101995 | DiamondâBlackfan anemia | 30 year old | male | erythroid E, CD34+, CD71 hi, CD45RAâ | D2 |
| GSM1019950 | DiamondâBlackfan anemia | 46 year old | female | multipotential P, CD34+, CD71â, CD45RAâ | D1 |
| GSM1019949 | DiamondâBlackfan anemia | 46 year old | female | myeloid M, CD34+, CD71 low, CD45RA+ | D1 |
| GSM1019948 | DiamondâBlackfan anemia | 46 year old | female | erythroid E, CD34+, CD71 hi, CD45RAâ | D1 |
| GSM1019947 | control | between 25 and 40 years old | female | multipotential P, CD34+, CD71â, CD45RAâ | C6 |
| GSM1019946 | control | between 25 and 40 years old | female | myeloid M, CD34+, CD71 low, CD45RA+ | C6 |
| GSM1019945 | control | between 25 and 40 years old | female | erythroid E, CD34+, CD71 hi, CD45RAâ | C6 |
| GSM1019944 | control | between 25 and 40 years old | female | multipotential P, CD34+, CD71â, CD45RAâ | C5 |
| GSM1019943 | control | between 25 and 40 years old | female | myeloid M, CD34+, CD71 low, CD45RA+ | C5 |
| GSM1019942 | control | between 25 and 40 years old | female | erythroid E, CD34+, CD71 hi, CD45RAâ | C5 |
| GSM101994 | control | between 25 and 40 years old | female | multipotential P, CD34+, CD71â, CD45RAâ | C4 |
| GSM1019940 | control | between 25 and 40 years old | female | myeloid M, CD34+, CD71 low, CD45RA+ | C4 |
| GSM1019939 | control | between 25 and 40 years old | female | erythroid E, CD34+, CD71 hi, CD45RAâ | C4 |
| GSM1019938 | control | between 25 and 40 years old | female | multipotential P, CD34+, CD71â, CD45RAâ | C3 |
| GSM1019937 | control | between 25 and 40 years old | female | myeloid M, CD34+, CD71 low, CD45RA+ | C3 |
| GSM1019936 | control | between 25 and 40 years old | female | erythroid E, CD34+, CD71 hi, CD45RAâ | C3 |
| GSM1019935 | control | between 25 and 40 years old | male | multipotential P, CD34+, CD71â, CD45RAâ | C2 |
| GSM1019934 | control | between 25 and 40 years old | male | myeloid M, CD34+, CD71 low, CD45RA+ | C2 |
| GSM1019933 | control | between 25 and 40 years old | male | erythroid E, CD34+, CD71 hi, CD45RAâ | C2 |
| GSM1019932 | control | between 25 and 40 years old | female | multipotential P, CD34+, CD71â, CD45RAâ | C1 |
| GSM101993 | control | between 25 and 40 years old | female | myeloid M, CD34+, CD71 low, CD45RA+ | C1 |
| GSM1019930 | control | between 25 and 40 years old | female | erythroid E, CD34+, CD71 hi, CD45RAâ | C1 |